Expert forum

Current situation, problems and directions of high-risk pregnancy research in China

  • Yi LIN
Expand
  • Central Laboratory of The International Peace Maternity & Child Health Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Embryo Original Diseases; Institute of Birth Defects and Rare Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
LIN Yi, E-mail: yilinonline@126.com.

Received date: 2021-10-28

  Accepted date: 2022-04-21

  Online published: 2022-04-28

Supported by

National Key R&D Program of China(2018YFC1002800);National Natural Science Foundation of China(82171669);Major Project of Shanghai Jiao Tong University Translational Medicine Awards Research(20210201)

Abstract

With the progressive initiation of the two- and three-child policy in China, and under the influence of various factors in society, the proportion of high-risk pregnancy has increased, especially those linked to advanced age conception (more than 35 years old). In pathological pregnancy, the incidence of recurrent miscarriage and preterm birth remains high. The diagnosis and treatment of common pregnancy complications such as preeclampsia and eclampsia are lagging behind. Diseases that cause maternal death have changed. The cases of deep vein thrombosis causing maternal deaths have increased. Expanding floating population increases the risk of adverse pregnancy outcomes. The widespread use of assisted reproduction has led to high risk of adverse pregnancy outcomes. The increase in the number of elder mothers has led to high risk in fetal birth defects. All of these have led to a new challenge in terms of maternal safety and care, urging scientists and clinicians to establish a more accurate risk assessment standard for pregnant women, especially for the elderly pregnant women, implement whole pregnancy management and standardized diagnosis and treatment, standardize the treatment for abortion, and establish a triple monitoring system for identifying maternal arterial rhythm, maternal heart rate and fetal heart rate. Finally, a hospital-home monitoring and warning system will be set up based on the Internet of things and information automation. This paper describes the current status, problems and directions of high-risk pregnancy research under the background of the new population policy, and provides new strategies for the protection of maternal and child health.

Cite this article

Yi LIN . Current situation, problems and directions of high-risk pregnancy research in China[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(4) : 403 -408 . DOI: 10.3969/j.issn.1674-8115.2022.04.001

References

1 姚秉彝, 唐龙英, 仲伟国, 等. 高危妊娠管理对妊娠结局的影响[J]. 中国妇幼保健, 2020, 35(3): 403-405.
1 YAO B Y, TANG L Y, ZHONG W G, et al. Impact of high-risk pregnancy management on pregnancy outcomes[J]. Matern Child Health Care China, 2020, 35(3): 403-405.
2 乐杰. 妇产科学[M]. 6版. 北京: 人民卫生出版社, 2004.
2 LE J. Obstetrics and gynecology[M]. 6th ed. Beijing: People's Medical Publishing House, 2004.
3 杨菊华, 王苏苏, 刘轶锋. 新中国70年: 人口老龄化发展趋势分析[J]. 中国人口科学, 2019(4): 30-42, 126.
3 YANG J H, WANG S S, LIU Y F. 70 years of China: analysis on the trend of population aging[J]. Chin J Popul Sci, 2019(4): 30-42, 126.
4 STEPHENSON M D, AWARTANI K A, ROBINSON W P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study[J]. Hum Reprod, 2002, 17(2): 446-451.
5 张孝栋, 张雅璐, 贾国平, 等. 中国低生育率研究进展: 一个文献综述[J]. 人口与发展, 2021, 27(6): 9-21.
5 ZHANG X D, ZHANG Y L, JIA G P, et al. Research progress on low fertility rate in China: a literature review[J]. Popul Dev, 2021, 27(6): 9-21.
6 叶傲霜, 吴晓雪, 陈苏慧, 等. 2010—2019年温州市孕产妇死亡率变化趋势及死因分析[J]. 预防医学, 2021, 33(1): 87-90.
6 YE A S, WU X X, CHEN S H, et al. Analysis of the maternal mortality rate and cause in Wenzhou during 2010 to 2019[J]. Prev Med, 2021, 33(1): 87-90.
7 周佳佳, 李木元, 刘佳政. “十四五”期间我国人口很可能进入零增长区间[N]. 人民政协报, 2021-12-02(2).
7 ZHOU J J, LI M Y, LIU J Z. It is likely to have zero population growth in China during the “14th Five-Year Plan” period[N]. Renmin Zhengxie Bao, 2021-12-02(2).
8 执行?联合国千年宣言?的行进图: 秘书长的报告[R/OL]. [2021-10-20]. https://undocs.org/zh/A/56/326.
8 The road map for the implementation of the United Nations Millennium Declaration: report of the Secretary-General[R/OL]. [2021-10-20]. https://undocs.org/zh/A/56/326.
9 BLENCOWE H, COUSENS S, JASSIR FB, et al. National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis[J]. Lancet Glob Health, 2016, 4(2): e98-e108.
10 WATSON C. Stillbirth rate rises dramatically during pandemic[J]. Nature, 2020, 585(7826): 490-491.
11 国家统计局. ?中国妇女发展纲要(2011?2020年)?终期统计监测报告[N]. 中国信息报, 2021-12-22(2).
11 National Bureau of Statistics of China. Final statistical monitoring report of Women's Development Program in China (2011?2020)[N]. Zhongguo Xinxi Bao, 2021-12-22(2).
12 国家统计局. ?中国儿童发展纲要(2011—2020年)?终期统计监测报告[N]. 中国信息报, 2021-12-23(2).
12 National Bureau of Statistics of China. Final statistical monitoring report of Children's Development Program in China (2011?2020)[N]. Zhongguo Xinxi Bao, 2021-12-23(2).
13 连漪. 妇幼健康步入高质量发展新阶段[J]. 中国卫生, 2021(6): 90-91.
13 LIAN Y. Maternal and child health enters a new stage of high-quality development[J]. China Health, 2021(6): 90-91.
14 国家卫生健康委员会. 母婴安全行动提升计划(2021—2025年)[EB/OL]. [2021-10-20]. http://www.gov.cn/zhengce/zhengceku/2021-10/15/content_5642740.htm.
14 National Health Commission of China. A plan to improve maternal and child safety actions (2021?2025)[EB/OL]. [2021-10-20]. http://www.gov.cn/zhengce/zhengceku/2021-10/15/content_5642740.htm.
15 SRIRAM S, SCHREIBER M D, MSALL M E, et al. Cognitive development and quality of life associated with BPD in 10-year-olds born preterm[J]. Pediatrics, 2018, 141(6): e20172719.
16 OGASAWARA M, AOKI K, OKADA S, et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages[J]. Fertil Steril, 2000, 73(2): 300-304.
17 SAY L, CHOU D, GEMMILL A, et al. Global causes of maternal death: a WHO systematic analysis[J]. Lancet Glob Health, 2014, 2(6): e323-e333.
18 杨孜, 张为远. 妊娠期高血压疾病诊治指南(2015)解读[J]. 中国实用妇科与产科杂志, 2015, 31(10): 886-893.
18 YANG Z, ZHANG W Y. Understanding Society of Obstetrics and Gynecology of Chinese Medical Association Guideline for the management of hypertensive disorders of pregnancy[J]. Chin J Pract Gynecol Obstet, 2015, 31(10): 886-893.
19 GOLDENBERG R L, CULHANE J F, IAMS J D, et al. Epidemiology and causes of preterm birth[J]. Lancet, 2008, 371(9606): 75-84.
20 HOWSON C P, KINNEY M V, MCDOUGALL L, et al. Born too soon: preterm birth matters[J]. Reprod Health, 2013, 10(Suppl 1): S1.
21 LIU L, JOHNSON H L, COUSENS S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000[J]. Lancet, 2012, 379(9832): 2151-2161.
22 瞿翠翠, 瞿晓娴, 刘小华. 不同年龄段辅助生殖受孕后母体结局分析[J]. 同济大学学报(医学版), 2020, 41(3): 314-318.
22 QU C C, QU X X, LIU X H. Maternal outcome after assisted reproductive conception in different age groups[J]. J Tongji Univ (Med Sci), 2020, 41(3): 314-318.
23 张雪, 刘凤杰, 于莹, 等. 辅助生殖技术对孕产妇及其子代健康状况的影响[J]. 中国妇幼保健, 2017, 32(9): 1969-1974.
23 ZHANG X, LIU F J, YU Y, et al. Effect of assisted reproductive technologies on health conditions of pregnant women and their babies[J]. Matern Child Health Care China, 2017, 32(9): 1969-1974.
24 卫生部发布?中国出生缺陷防治报告(2012)?[J]. 中国药房, 2012, 23(39): 3693.
24 Report on the Prevention and Control of Birth Defects in China (2012) issued by the Ministry of Health of China[J]. China Pharmacy, 2012, 23(39): 3693.
25 章玉霜, 金海华. 新生儿出生缺陷监测及相关危险因素分析[J]. 中国妇幼保健, 2019, 34(9): 2069-2071.
25 ZHANG Y S, JIN H H. Surveillance of birth defects in newborns and analysis of related risk factors[J]. Matern Child Health Care China, 2019, 34(9): 2069-2071.
26 陈慧. 妊娠风险预警评估管理模式在高危妊娠管理中的应用效果研究[J]. 黑龙江科学, 2022, 13(2): 116-117.
26 CHEN H. Study on the application effect of pregnancy risk early warning assessment management model in high-risk pregnancy management[J]. Heilongjiang Sci, 2022, 13(2): 116-117.
27 董爱芹, 解秀霞, 李红霞. 高危妊娠孕妇特征及妊娠结局影响因素研究[J]. 华南预防医学, 2021, 47(9): 1198-1200.
27 DONG A Q, XIE X X, LI H X. Study on the influncing factors of maternal characteristics and pregnancy outcomes with high risk pregnancy[J]. S China J Prev Med, 2021, 47(9): 1198-1200.
28 陈丽华. 高危妊娠孕妇对胎心监护仪的应用认知度及其影响因素[J]. 医疗装备, 2021, 34(21): 168-169.
28 CHEN L H. The general awareness and its influencing factors of fetal heart monitor in high-risk pregnancy[J]. Med Equip, 2021, 34(21): 168-169.
29 陈秋玲, 高爽. 胎心监护与脐动脉血流监测对胎儿窘迫的诊断价值[J]. 中国妇幼保健, 2021, 36(20): 4867-4869.
29 CHEN Q L, GAO S. Value analysis of dynamic monitoring of fetal heart monitoring and umbilical artery blood flow in the diagnosis of fetal distress[J]. Matern Child Health Care China, 2021, 36(20): 4867-4869.
30 蔡凤娥, 甘玉杰, 熊小英, 等. 高危妊娠妇女区域产科联盟内互联网+远程胎心监护中心服务模式的应用效果[J]. 中国医药科学, 2021, 11(16): 91-94.
30 CAI F E, GAN Y J, XIONG X Y, et al. Application effect of the service mode of internet plus remote fetal heart monitoring center in the regional obstetric alliance of high-risk pregnant women[J]. China Med Pharm, 2021, 11(16): 91-94.
31 李冬云, 苏虹, 匡静, 等. 远程胎心监护系统在新冠肺炎疫情期间的应用分析[J]. 云南医药, 2021, 42(4): 356-358.
31 LI D Y, SU H, KUANG J, et al. Analysis on application of long-distance fetal heart monitor system during the COVID-19 pandemics[J]. Med Pharm Yunnan, 2021, 42(4): 356-358.
Outlines

/